Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. DFTX
3. SPCX
4. FRVO
5. MPLT
6. CART
7. HIVE
8. INTC
9. APGE
10. ABBV

Go back to Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026
(NASDAQ: LEGN) Delayed: 27.93 --0 (-0%)
Previous Close $27.93    52 Week High $ 
Open $27.93    52 Week Low $ 
Day High $27.93    P/E N/A 
Day Low $27.93    EPS $ 
Volume 1,002